Get notified regarding key financial metrics and revenue changes at CepheidLearn more
Banner background

Summary - Funding Rounds

Founding Date

1996

Total Funding

$8.1 m

Investors

In total, Cepheid had raised $8.1 m. Cepheid is a subsidiary of Danaher

Cepheid Revenue Breakdown

Embed Graph

Cepheid revenue breakdown by business segment: 15.4% from Clinical Systems, 79.3% from Clinical Reagents and 5.3% from Non-Clinical

Cepheid revenue breakdown by geographic segment: 59.0% from North America and 41.0% from International

Cepheid Income Statement

Annual

USDFY, 2015

Revenue

538.6m

Revenue growth, %

15%

Cost of goods sold

269.9m

Gross profit

268.7m

Gross profit Margin, %

50%

Sales and marketing expense

115.4m

R&D expense

115.8m

General and administrative expense

62.6m

Operating expense total

299.6m

EBIT

(30.9m)

EBIT margin, %

(6%)

Interest expense

16.4m

Interest income

1.9m

Pre tax profit

(47.3m)

Income tax expense

1.3m

Net Income

(48.5m)

EPS

(0.7)

Quarterly

USDQ1, 2016Q2, 2016Q3, 2016

Revenue

144.8m146.0m158.5m

Cost of goods sold

72.6m73.2m83.4m

Gross profit

72.2m72.8m75.1m

Gross profit Margin, %

50%50%47%

Sales and marketing expense

28.8m29.9m29.3m

R&D expense

29.9m33.6m29.9m

General and administrative expense

15.1m15.4m18.7m

Operating expense total

74.4m80.2m80.8m

EBIT

(2.2m)(7.4m)(5.7m)

EBIT margin, %

(2%)(5%)(4%)

Interest expense

3.8m3.8m3.9m

Interest income

660.0k799.0k873.0k

Pre tax profit

(5.9m)(10.1m)(9.7m)

Income tax expense

731.0k115.0k1.2m

Net Income

(6.6m)(10.2m)(10.9m)

EPS

(0.1)(0.1)(0.1)

Cepheid Balance Sheet

Annual

USDFY, 2015

Cash

112.6m

Accounts Receivable

66.6m

Prepaid Expenses

18.5m

Inventories

148.7m

Current Assets

556.5m

PP&E

127.6m

Goodwill

39.7m

Total Assets

821.6m

Accounts Payable

57.8m

Current Liabilities

142.5m

Long-term debt

287.9m

Total Debt

287.9m

Total Liabilities

451.7m

Common Stock

449.7m

Additional Paid-in Capital

263.4m

Retained Earnings

(342.2m)

Total Equity

370.0m

Debt to Equity Ratio

0.8 x

Debt to Assets Ratio

0.4 x

Financial Leverage

2.2 x

Quarterly

USDQ1, 2016Q2, 2016Q3, 2016

Cash

89.8m100.3m115.7m

Accounts Receivable

72.6m62.8m81.9m

Prepaid Expenses

26.6m23.4m23.1m

Inventories

150.4m156.8m155.7m

Current Assets

542.0m566.5m629.9m

PP&E

144.0m152.0m151.2m

Goodwill

39.7m39.7m39.7m

Total Assets

818.5m841.4m847.4m

Accounts Payable

58.0m64.3m56.0m

Current Liabilities

133.4m149.6m146.5m

Long-term debt

284.3m287.0m289.8m

Total Debt

284.3m287.0m289.8m

Total Liabilities

441.3m463.7m466.7m

Common Stock

453.9m454.5m458.9m

Additional Paid-in Capital

272.5m282.3m292.8m

Retained Earnings

(348.8m)(359.1m)(370.0m)

Total Equity

377.2m377.7m380.6m

Debt to Equity Ratio

0.8 x0.8 x0.8 x

Debt to Assets Ratio

0.3 x0.3 x0.3 x

Financial Leverage

2.2 x2.2 x2.2 x

Cepheid Cash Flow

Annual

USDFY, 2015

Net Income

(48.5m)

Depreciation and Amortization

33.5m

Accounts Receivable

2.3m

Inventories

(15.1m)

Accounts Payable

4.2m

Cash From Operating Activities

31.1m

Purchases of PP&E

(37.7m)

Cash From Investing Activities

(39.9m)

Long-term Borrowings

(162.0k)

Cash From Financing Activities

27.5m

Net Change in Cash

15.9m

Quarterly

USDQ1, 2016Q2, 2016Q3, 2016

Net Income

(6.6m)(16.8m)(27.7m)

Depreciation and Amortization

9.0m18.2m28.4m

Accounts Receivable

(6.1m)3.7m(15.4m)

Inventories

(1.7m)(8.1m)(7.2m)

Accounts Payable

(1.4m)6.0m3.9m

Cash From Operating Activities

(9.1m)24.7m25.5m

Purchases of PP&E

(22.7m)(34.2m)(49.2m)

Cash From Investing Activities

(18.0m)(41.7m)(32.2m)

Long-term Borrowings

(43.0k)(85.0k)(128.0k)

Cash From Financing Activities

4.2m4.8m9.2m

Net Change in Cash

(22.7m)(12.2m)3.2m

Cepheid Ratios

USDFY, 2015

Revenue/Employee

316.8k

Debt/Equity

0.8 x

Debt/Assets

0.4 x

Financial Leverage

2.2 x

Cepheid Operating Metrics

Jun, 2021

Patent Applications (US)

101

Patents (US)

128

Trademarks (US)

2

Cepheid Employee Rating

3.9322 votes
Culture & Values
3.6
Work/Life Balance
3.6
Senior Management
3.5
Salary & Benefits
3.6
Career Opportunities
3.8
Source